Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 2Smoking Cessation 1Multiple Pulmonary Nodules 1Liver Cirrhosis 1

Interventions

Cyclophosphamide 517Bevacizumab 488Carboplatin 424pembrolizumab 387Paclitaxel 385Gemcitabine 372Cisplatin 366Docetaxel 323Rituximab 316Radiotherapy 296Nivolumab 247Doxorubicin 243Dexamethasone 240Fluorouracil 225Capecitabine 214Oxaliplatin 211Erlotinib Hydrochloride 206fludarabine phosphate 201Etoposide 188Cetuximab 186Lenalidomide 177Pemetrexed 176Bortezomib 174Trastuzumab 173Filgrastim 171fludarabine 166Prednisone 166Leucovorin 166Cytarabine 166Irinotecan 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Has results × Tomography × Clear all
NCT03824535 2025-04-09

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

Stanford University

Phase 2 Completed
15 enrolled 7 charts

Smoking Cessation, Multiple Pulmonary Nodules

NCT02695628 2024-01-31

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Stanford University

Phase 2 Completed
5 enrolled 8 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

NCT01395030 2018-09-26

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

Queen's Medical Center

Phase 2 Completed
64 enrolled 13 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡